Dergiler / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 4

M235T polymorphism in the angiotensinogen gene and cardiovascular disease: An updated meta-analysis of 39 case–control comparisons

Sayfa
222–232
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, current evidence suggests that there is no suchassociation in the Caucasian population. (Anatol J Cardiol 2019; 21: 222-32)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: M235T polymorphism of the angiotensinogen (AGT) gene has been linked with cardiovascular disease (CVD).
📊
Temel Bulgular & Veri:The aim of this metaanalysis was to investigate whether combined evidence supports this association.Methods: A systematic search was conducted for studies published up to October 2018 that evaluate the association between AGT M235Tpolymorphism and risk of CVD.
💡
Sonuç & Katkı:However, current evidence suggests that there is no suchassociation in the Caucasian population. (Anatol J Cardiol 2019; 21: 222-32)
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: M235T polymorphism of the angiotensinogen (AGT) gene has been linked with cardiovascular disease (CVD). The aim of this metaanalysis was to investigate whether combined evidence supports this association.Methods: A systematic search was conducted for studies published up to October 2018 that evaluate the association between AGT M235Tpolymorphism and risk of CVD. Case–control studies were identified, and the association between AGT M235T polymorphism and CVD risk wasassessed using genetic models.Results: Thirty-nine comparisons from 38 studies were collected, and a meta-analysis and subgroup analysis was performed based on ethnicity. In the overall population (9225 cases and 8406 controls), the occurrence of CVD was found to be associated with AGT M235T polymorphismin both allelic [T vs. M: odds ratio (OR)=1.16] and recessive (TT vs. MT+MM: OR=1.14) models. In subgroup analyses, a significant associationwas identified between AGT M235T polymorphism and CVD risk in East Asian subgroups in allelic (T vs. M: OR=1.46), homozygous (TT vs. MM:OR=1.78), dominant (MT+TT vs. MM: OR=1.47), and recessive (TT vs. MT+MM: OR=1.68) models, but there was no significant association inCaucasian populations.Conclusion: Among East Asians, the AGT variant M235T is associated with CVD risk. However, current evidence suggests that there is no suchassociation in the Caucasian population. (Anatol J Cardiol 2019; 21: 222-32)

🔖

Bu Makaleye Atıf Yap

ZHAI, C., CONG, H., ZHANG, H., HOU, K., ZHANG, Y., ZHANG, Y. (2019). M235T polymorphism in the angiotensinogen gene and cardiovascular disease: An updated meta-analysis of 39 case–control comparisons. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 4, 222–232. https://ajindex.com/articles/366790

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015; 132: 1667-78
  2. Ounpuu S, Negassa A, Yusuf S. INTER-HEART: A global study of risk factors for acute myocardial infarction. Am Heart J 2001; 141: 711-21
  3. Roberts R, Stewart AF. Genes and coronary artery disease: where are we? J Am Coll Cardiol 2012; 60: 1715-21
  4. Meininger JC, Hayman LL, Coates PM, Gallagher PR. Genetic and environmental influences on cardiovascular disease risk factors in adolescents. Nurs Res 1998; 47: 11-8
  5. Xia J, Cai W, Peng C. Association of APOA5 T1131C polymorphism and risk of coronary artery disease. Int J Clin Exp Med 2015; 8: 8986-94
  6. Yuepeng J, Zhao X, Zhao Y, Li L. Gene polymorphism associated with TNF-α (G308A) IL-6 (C174G) and susceptibility to coronary atherosclerotic heart disease: A meta-analysis. Medicine (Baltimore) 2019; 98: e13813
  7. Ryu SK, Cho EY, Park HY, Im EK, Jang YS, Shin GJ, et al. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis. Yonsei Med J 2002; 43: 461-72
  8. Wang JG, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000; 410: 289-302
  9. Koh KK, Han SH, Oh PC, Shin EK, Quon MJ. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction. Atherosclerosis 2010; 209: 307-13
  10. Heidari F, Vasudevan R, Mohd ASZ, Ismail P, Etemad A, Pishva SR, et al. Association of insertion/deletion polymorphism of angiotensinconverting enzyme gene among Malay male hypertensive subjects in response to ACE inhibitors. J Renin Angiotensin Aldosterone Syst 2015; 16: 872-9
  11. Kondo H, Ninomiya T, Hata J, Hirakawa Y, Yonemoto K, Arima H, et al. Angiotensin I-converting enzyme gene polymorphism enhances the effect of hypercholesterolemia on the risk of coronary heart disease in a general Japanese population: the hisayama study. J Atheroscler Thromb 2015; 22: 390-403
  12. Batalla A, Alvarez R, Reguero JR, Hevia S, Iglesias-Cubero G, Alvarez V, et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 2000; 46: 1910-5
  13. Gardemann A, Stricker J, Humme J, Nguyen QD, Katz N, Philipp M, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of